Notice of Meeting, 104155-104156 [2024-30336]
Download as PDF
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices
(d) Data reported by each first-tier
subcontractor providing services under
the contract if required to do so.
Section 743 of Division C of the
Consolidated Appropriations Act, 2010
(Pub. L. 111–117) requires executive
agencies covered by the Federal
Activities Inventory Reform Act (Pub. L.
105–270), except DoD, to submit to
OMB an annual inventory of activities
performed by service contractors. DoD is
exempt from this reporting requirement
because 10 U.S.C. 4505(c) already
require DoD to develop an annual
service contract inventory. Civilian
agencies use the service contract
information provided by FAR clauses
52.204–14 and 52.204–15 to supplement
agency annual service contract reporting
requirements with the contractorprovided service contract reporting
information.
5. FAR 52.204–16 and 52.204–18,
Commercial and Government Entity
(CAGE) Code Reporting and
Maintenance. The provision at FAR
52.204–16, Commercial and
Government Entity Code Reporting,
require offerors to provide their CAGE
code, including name and location
address, with their offer. The CAGE
code must be for that name and location
address. The CAGE code is required
prior to award. The clause at FAR
52.204–18, Commercial and
Government Entity Code Maintenance,
requires contractors to maintain their
CAGE code throughout the life of the
contract for each location of contract,
including subcontract, performance.
For contractors registered in SAM, the
Defense Logistics Agency (DLA) CAGE
Branch shall only modify data received
from SAM in the CAGE master file if the
contractor initiates those changes via
update of its SAM registration.
Contractors undergoing a novation or
change-of-name agreement shall notify
the contracting officer in accordance
with FAR subpart 42.12. The contractor
shall communicate any change to the
CAGE code to the contracting officer
within 30 days after the change, so that
a modification can be issued to update
the CAGE code on the contract.
Contractors located in the U.S. or its
outlying areas that are not registered in
SAM shall submit written change
request to the DLA CAGE Branch.
Contractors located outside the U.S. and
its outlying areas that are not registered
in SAM shall contact the appropriate
National Codification Bureau points of
contact to request CAGE changes.
6. FAR 52.204–17, Ownership or
Control of Offeror. This provision
requires offerors to represent whether
they are owned or controlled by another
VerDate Sep<11>2014
20:12 Dec 19, 2024
Jkt 265001
entity, and if so, to provide the CAGE
code and name of such entity.
The CAGE code system may be used,
among other things, to—
(a) Exchange data with another
contracting activity, including contract
administration activities and contract
payment activities;
(b) Exchange data with another
system that requires the unique
identification of a contractor entity; or
(c) Identify when offerors are owned
or controlled by another entity.
7. FAR 52.204–20, Predecessor of
Offeror. This provision requires offerors
to identify if the offeror is, within the
last three years, a successor to another
entity that received a Federal
Government award and, if so, to provide
the CAGE code and legal name of the
predecessor.
The information on predecessors is
used to identify such entities in the
Federal Awardee Performance and
Integrity Information System (FAPIIS) to
allow retrieval of integrity and
performance data on the most recent
predecessor of an apparent successful
offeror to whom award is anticipated.
FAR 9.104–6 requires contracting
officers to consult FAPIIS before
awarding a contract that exceeds the
simplified acquisition threshold.
8. FAR 52.204–23, Prohibition on
Contracting for Hardware, Software, and
Services Developed or Provided by
Kaspersky Lab Covered Entities. This
clause requires contractors to report, in
writing, to the contracting officer or, in
the case of DoD, to the website at
https://dibnet.dod.mil, any instance
when the contractor identifies a covered
article provided to the Government
during contract performance, or if
contractors are notified of such an event
by subcontractors at any tier or any
other source.
Agency personnel will use the
collected information to identify and
remove prohibited hardware, software,
or services from Government use. This
information collection is required to
comply with section 1634 of Division A
of the National Defense Authorization
Act for Fiscal Year 2018 (Pub. L. 115–
91).
C. Annual Burden
Respondents: 353,291.
Total Annual Responses: 843,253.
Total Burden Hours: 387,083.
Obtaining Copies: Requesters may
obtain a copy of the information
collection documents from the GSA
Regulatory Secretariat Division by
calling 202–501–4755 or emailing
GSARegSec@gsa.gov. Please cite OMB
Control No. 9000–0189, Certain Federal
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
104155
Acquisition Regulation Part 4
Requirements.
Janet Fry,
Director, Federal Acquisition Policy Division,
Office of Governmentwide Acquisition Policy,
Office of Acquisition Policy, Office of
Governmentwide Policy.
[FR Doc. 2024–30452 Filed 12–19–24; 8:45 am]
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency For Healthcare Research and
Quality
Notice of Meeting
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ)
announces a Special Emphasis Panel
(SEP) meeting on ‘‘Implementing and
Evaluating Patient-Centered Clinical
Decision Support Strategies in RealWorld Settings(U18)’’
DATES: January 10th, 2025
ADDRESSES: Agency for Healthcare
Research and Quality (Video Assisted
Review), 5600 Fishers Lane, Rockville,
Maryland 20857.
FOR FURTHER INFORMATION CONTACT:
Jenny Griffith, Committee Management
Officer, Office of Extramural Research,
Education and Priority Populations,
Division of Policy, Coordination, and
Analysis, Agency for Healthcare
Research and Quality, (AHRQ), 5600
Fishers Lane, Rockville, Maryland
20857. Telephone: (301) 427–1557.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by AHRQ, and agree to
be available, to conduct on an as needed
basis, scientific reviews of applications
for AHRQ support. Individual members
of the Panel do not attend regularly
scheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
The SEP meeting referenced above
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. 1009(d), 5 U.S.C. 552b(c)(4),
and 5 U.S.C. 552b(c)(6). Grant
applications for ‘‘Implementing and
Evaluating Patient-Centered Clinical
Decision Support Strategies in RealWorld Settings(U18)’’ are to be reviewed
and discussed at this meeting. The grant
applications and the discussions could
SUMMARY:
E:\FR\FM\20DEN1.SGM
20DEN1
104156
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Agenda items for this meeting are
subject to change as priorities dictate.
Dated: December 16, 2024.
Marquita Cullom,
Associate Director.
[FR Doc. 2024–30336 Filed 12–19–24; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Information collection notice.
AGENCY:
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project (new):
‘‘Supporting and Evaluating AHRQ’s
Long COVID Care Network.’’
DATES: Comments on this notice must be
received by February 18, 2025.
ADDRESSES: Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by
email at
REPORTSCLEARANCEOFFICER@
ahrq.hhs.gov.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at
REPORTSCLEARANCEOFFICER@
ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
ddrumheller on DSK120RN23PROD with NOTICES1
Supporting and Evaluating AHRQ’s
Long COVID Care Network
Long COVID is a chronic condition in
which people continue to experience
persistent, varying, and potentially
disabling impacts after the acute
COVID–19 illness. Up to one third of
people with COVID–19 experience Long
COVID with the numbers higher in
females, transgender and bisexual
people, people without a college degree,
VerDate Sep<11>2014
20:12 Dec 19, 2024
Jkt 265001
and people with disability. Some of
these groups often face barriers that can
worsen the impact of Long COVID on
their lives and complicate recovery.
Some of the barriers they face include
difficulty with healthcare access,
communication and internet
accessibility, lack of health insurance,
lower health literacy, greater difficulty
using patient portals and telemedicine,
and greater medical and social
vulnerabilities.
Clinics to provide outpatient Long
COVID care have emerged across the
country to offer coordinated,
multidisciplinary care that meets the
complex, diverse, multi-system, and
specialized needs of people with Long
COVID. There are some Long COVID
clinic models that share common
elements including care coordination
and access to multidisciplinary care.
Though these clinics meet critical needs
in the healthcare system, they face
significant challenges including staffing
shortages; long patient waitlists; lack of
funding or reimbursement for some
services; lack of clear treatment
protocols; limited capacity to provide
timely, comprehensive, coordinated,
and person-centered care; and limited
clinician knowledge and training in
Long COVID management. Other
barriers these clinics face include the
limited number of Long COVID clinics
and specialists, concentration of clinics
in academic centers and urban areas,
late recognition of Long COVID
symptoms by clinicians, and delayed
referral to Long COVID clinics or
appropriate specialists.
In response, AHRQ awarded grants to
12 multidisciplinary Long COVID
clinics across the country (the ‘‘AHRQ
Long COVID Care Network’’) with the
goal to expand access to comprehensive,
coordinated, and person-centered care
for people with Long COVID,
particularly underserved populations
that are disproportionately impacted by
the effects of Long COVID. Specifically,
the grants are designed to expand access
and care, develop and implement new
or improved care delivery models, foster
best practices for Long COVID
management, and support the primary
care community in Long COVID
education and management.
The information and data collected
for this study will facilitate an
evaluation of the outcomes of AHRQ’s
Long COVID Care Network. The
evaluation reflects AHRQ’s mission to
produce evidence to make healthcare
safer, higher quality, more accessible,
equitable, and affordable; and to work
within the U.S. Department of Health
and Human Services and with other
partners to make sure that the evidence
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
is understood and used. This study is a
new data collection request, and the
data to be collected are not available
elsewhere unless obtained through this
data collection.
This project seeks to assess the
following:
(1) How is the AHRQ Long COVID
Care Network implementing strategies
to:
(a) expand access to comprehensive,
coordinated, person-centered care,
(b) engage clinicians in Long COVID
education and management, and
(c) educate patients and communities
about Long COVID?
(2) What was the reach of the AHRQ
Long COVID Care Network strategies,
especially to underserved populations
that are disproportionately impacted by
the effects of Long COVID?
(3) What were the patterns of:
(a) service utilization,
(b) patient outcomes and experiences,
(c) referral streams, and
(d) primary care communication and
coordination within the AHRQ Long
COVID Care Network?
To answer these research questions
AHRQ will implement two new data
collections that require OMB approval.
These data collections include:
(1) Grantee Interviews—Conducted
during annual site visits. At each site
visit, up to five 90-minute interviews
will be conducted—for a total of 60
interviews across the 12 sites. Each
interview will include up to two
respondents—for a total of 120
respondents across the sites. The
interview respondents will include
grantee principal investigators, research
and clinical staff at grantee Long COVID
clinics, and representatives from grantee
partner organizations (such as primary
care practices and community
organizations). The primary purpose of
the interviews is to query about how the
grantees developed and implemented
new or improved care delivery models,
implementation strategies, and
operational workflows; identified
barriers and facilitators to
implementation and mitigation
strategies for implementation
challenges; and considered the potential
sustainability of their program when
AHRQ funding ends.
(2) Grantee Survey—The survey will
be administered to each grantee
annually. Each grantee’s assigned
evaluation liaison, or their designated
representative, will respond to the
survey. The primary purpose of the
survey is to collect data on the services
and personnel at grantee Long COVID
clinics and the costs and resources
associated with the implementation of
the grant.
E:\FR\FM\20DEN1.SGM
20DEN1
Agencies
[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Pages 104155-104156]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30336]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency For Healthcare Research and Quality
Notice of Meeting
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ)
announces a Special Emphasis Panel (SEP) meeting on ``Implementing and
Evaluating Patient-Centered Clinical Decision Support Strategies in
Real-World Settings(U18)''
DATES: January 10th, 2025
ADDRESSES: Agency for Healthcare Research and Quality (Video Assisted
Review), 5600 Fishers Lane, Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management
Officer, Office of Extramural Research, Education and Priority
Populations, Division of Policy, Coordination, and Analysis, Agency for
Healthcare Research and Quality, (AHRQ), 5600 Fishers Lane, Rockville,
Maryland 20857. Telephone: (301) 427-1557.
SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of
experts in fields related to health care research who are invited by
AHRQ, and agree to be available, to conduct on an as needed basis,
scientific reviews of applications for AHRQ support. Individual members
of the Panel do not attend regularly scheduled meetings and do not
serve for fixed terms or a long period of time. Rather, they are asked
to participate in particular review meetings which require their type
of expertise.
The SEP meeting referenced above will be closed to the public in
accordance with the provisions set forth in 5 U.S.C. 1009(d), 5 U.S.C.
552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for
``Implementing and Evaluating Patient-Centered Clinical Decision
Support Strategies in Real-World Settings(U18)'' are to be reviewed and
discussed at this meeting. The grant applications and the discussions
could
[[Page 104156]]
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Agenda items for this meeting are subject to change as priorities
dictate.
Dated: December 16, 2024.
Marquita Cullom,
Associate Director.
[FR Doc. 2024-30336 Filed 12-19-24; 8:45 am]
BILLING CODE 4160-90-P